HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G F Samelis Selected Research

Zoledronic Acid (Zometa)

10/2011Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: an institutional report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G F Samelis Research Topics

Disease

2Prostatic Neoplasms (Prostate Cancer)
10/2011 - 06/2003
2Neoplasms (Cancer)
10/2009 - 06/2005
1Melanoma (Melanoma, Malignant)
10/2009
1Skin Neoplasms (Skin Cancer)
10/2009
1Colorectal Neoplasms (Colorectal Cancer)
06/2005

Drug/Important Bio-Agent (IBA)

2Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2011 - 06/2005
2EstramustineFDA Link
10/2011 - 06/2003
2Hormones (Hormone)IBA
10/2011 - 06/2003
1GemcitabineFDA Link
10/2011
1Zoledronic Acid (Zometa)FDA Link
10/2011
1Docetaxel (Taxotere)FDA Link
10/2011
1Irinotecan (Camptosar)FDA LinkGeneric
06/2005
1Leucovorin (Folinic Acid)FDA Link
06/2005
1Fluorouracil (Carac)FDA LinkGeneric
06/2005
1Mitoxantrone (Novantrone)FDA LinkGeneric
06/2003
1AndrogensIBA
06/2003

Therapy/Procedure

1Drug Therapy (Chemotherapy)
10/2011
1Therapeutics
10/2009